Surfactant therapy in acute respiratory distress syndrome due to hydrocarbon aspiration.
Hydrocarbon aspiration causes acute lung injury, which may lead to acute respiratory distress syndrome. Surfactant has been shown to be beneficial in experimentally-induced hydrocarbon-associated acute respiratory distress syndrome. However, there has not been a clinical study evaluating the effect of surfactant application on hydrocarbon aspiration in humans. We report a 17-month-old boy with acute respiratory distress syndrome due to hydrocarbon aspiration and was successfully treated with surfactant application.
Division of Paediatric Intensive Care, Department of Pediatrics, Faculty of Medicine, Cukurova University, 01330 Adana, Turkey.
O O
OO
Horoz
D
D
Yildizdas
H L
HL
Yilmaz
D000473:Alkanes / Q000506:poisoning*; D000890:Anti-Infective Agents / Q000008:administration & dosage; D001688:Biological Products / Q000008:administration & dosage*; D002443:Ceftriaxone / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003422:Critical Care; D004298:Dopamine / Q000008:administration & dosage; D006801:Humans; D006838:Hydrocarbons / Q000506:poisoning*; D007223:Infant; D008297:Male; D011175:Positive-Pressure Respiration; D011663:Pulmonary Surfactants / Q000008:administration & dosage*; D011859:Radiography; D053120:Respiratory Aspiration / Q000150:complications* / Q000000981:diagnostic imaging; D012128:Respiratory Distress Syndrome / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy*; D014132:Trachea; D014421:Turkey
D000473:Alkanes; D000890:Anti-Infective Agents; D001688:Biological Products; D006838:Hydrocarbons; D011663:Pulmonary Surfactants; D002443:Ceftriaxone; C004544:naphtha; C072197:beractant; D004298:Dopamine